Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-01-23Transcranial Magnetic Stimulation and Its Effects on Mayor Depressive Disorder and Smoking Cessation
-
CLINICAL_TRIALS study record update · 2023-01-19Electrophysiological Correlates of Cognition in Depression
-
CLINICAL_TRIALS study record update · 2023-01-05The Antidepressant Advisor: A Decision Support System for UK Primary Care - a Feasibility Study: Study 3
-
CLINICAL_TRIALS study record update · 2023-01-04Near-infrared Radiation-transcranial Photobiomodulation for Major Depressive Disorder: From Cellular, Animal Studies to a Sham-controlled Double-blind Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-12-22Neurobiological Effects of Light on MDD
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-13A Cluster Randomized Controlled Trial of Enhanced Versus Standard Measurement-Based Care Implementation for Depression
-
CLINICAL_TRIALS study record update · 2022-12-12Clinical Pilot of Augmented Human Intelligence in Major Depressive Disorder (AHI/Depression Pilot)
-
CLINICAL_TRIALS study record update · 2022-12-09Feasibility and Acceptability Study of "Mamá, te Entiendo": an App-based Intervention for Reducing Depressive Symptoms in Postpartum Women
-
CLINICAL_TRIALS study record update · 2022-12-02A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control
-
CLINICAL_TRIALS study record update · 2022-12-01Impact of Covid-19 Pandemic on Patients With Unipolar Depressive Disorder: Effects of Discontinuing Continuation or Maintenance Electroconvulsive Therapy
-
CLINICAL_TRIALS study record update · 2022-11-29Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes: Role of Inflammation, Kynurenine Pathway, and Structural and Functional Brain Connectivity as Biomarkers
-
CLINICAL_TRIALS study record update · 2022-11-22Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients
-
CLINICAL_TRIALS study record update · 2022-11-10A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-11-03Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder: a Study Protocol for a Multicenter, Prospective, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-11-03Study of Neural Responses Induced by Simulated Antidepressants
-
CLINICAL_TRIALS study record update · 2022-11-01Psychological Interventions and Transcranial Direct Current Stimulation for the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-11-01Effects of Electroconvulsive Therapy on Neuronal, Immunological and Hormonal Parameters in Patients With Affective Disorders
-
CLINICAL_TRIALS study record update · 2022-10-25A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
-
CLINICAL_TRIALS study record update · 2022-10-20A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
-
CLINICAL_TRIALS study record update · 2022-10-19Prospective Biomarkers for Treatment Response in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-10-17Chinese Longitudinal and Systematic Study of Bioplar Disorder
-
CLINICAL_TRIALS study record update · 2022-10-12Double-blind, Randomized, Placebo-Controlled Pilot Study of the Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-10-12AXS-05-MDD-301: A Randomized, Double-Blind, Placebo-Controlled Trial of AXS-05 in Subjects With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-10-12An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-10-12Impact of Comprehensive Pharmacogenomic Testing on the Treatment of Major Depressive Disorder